• ADMA Biologics Launches COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay americanpharmaceuticalreview
    September 04, 2020
    ADMA Biologics announced the launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA assay for the detection of SARS-CoV-2 neutralizing antibodies in plasma.
  • Adma Biologics Launches COVID-19 Assay contractpharma
    September 04, 2020
    ​Adma Biologics Inc., an end-to-end commercial biopharmaceutical company, has launched COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA assay for the detection of SARS-CoV-2 neutralizing antibodies in plasma.
PharmaSources Customer Service